Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The use of long-acting octreotide improves quality of life (QOL) in patients with cancer who have loperamide-refractory diarrhoea,

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Mystakidou K, Katsouda E, Tsilika E, Smyrniotis V, Vassiliou I, Tsiatas M, Vlahos L.Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment. Anticancer Research 26: 2325-2328, No. 3, May-Jun 2006

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    The use of long-acting octreotide improves quality of life (QOL) in patients with cancer who have loperamide-refractory diarrhoea,. Pharmacoecon. Outcomes News 509, 9 (2006). https://doi.org/10.2165/00151234-200605090-00026

    Download citation

    Keywords

    • Public Health
    • Health Outcome
    • Energy Level
    • Medical Intervention
    • Analog Scale